We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Handling Procedures Affect Interleukin 6 Levels in Samples

By LabMedica International staff writers
Posted on 26 Oct 2019
Print article
Image: The cobas e 601 is a fully automated analyzer that uses a patented electrochemiluminescence (ECL) technology for immunoassay analysis (Photo courtesy of Roche Diagnostics).
Image: The cobas e 601 is a fully automated analyzer that uses a patented electrochemiluminescence (ECL) technology for immunoassay analysis (Photo courtesy of Roche Diagnostics).
Interleukin‐6 (IL‐6), a pleiotropic cytokine, is released by a variety of cell types such as immune cells, endothelial cells, and even certain tumor cells. It is a classic proinflammation cytokine which exhibits broad‐ranging biological activities by involved in the intricate cellular communication.

Pre‐analytical variables for the test include blood collection tubes, specimen storage temperature and time, plasma or serum separation, and pretreatment steps. Studies have shown pre‐analytical handling steps can influence sample quality and analytical results. The fact that the half‐life of IL‐6 is short, degradation and production may occur simultaneously during storage under unseparated condition.

Medical Laboratory Scientists at the Southern Medical University (Guangzhou, China) collected EDTA plasma and serum samples from 45 healthy individuals. The participants were divided into three groups to perform different handling procedures. Different centrifugal timing, storage temperature, and time were executed on the samples. All samples were centrifuged at 1760 ×g for 15 minutes, but centrifugal timing selection was different in three groups. Serum and plasma IL‐6 levels were assayed through the electrochemiluminescence (ECLIA) method on Cobas e 601 analyzer. The changed trends of IL‐6 levels were analyzed.

The team reported that at baseline, while the paired plasma and serum IL‐6 values had a good correlation, the plasma levels were higher than serum. In general, the unseparated EDTA plasma kept steady with time. With the increase in storage temperature and time, a more pronounced rise in unseparated serum IL‐6 was observed. Nevertheless, the samples in the group, which was centrifuged and separated immediately kept stable after a different temperature and longtime storage.

The authors concluded that factors that affect changes in cytokine levels are various and incorrect sample handling procedures may result in false results. In general, unseparated EDTA plasma can keep IL‐6 steady for up to 24 hours. In not refrigerated conditions, unseparated serum is recommended to measure IL‐6 as soon as possible. Otherwise, the serum separation should be done. The study was published in the September 2019 issue of the Journal of Clinical Laboratory Analysis.

Related Links:
Southern Medical University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.